Stuart W. Bright

611 total citations
8 papers, 516 citations indexed

About

Stuart W. Bright is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Stuart W. Bright has authored 8 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Stuart W. Bright's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Receptor Mechanisms and Signaling (2 papers) and T-cell and B-cell Immunology (2 papers). Stuart W. Bright is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Receptor Mechanisms and Signaling (2 papers) and T-cell and B-cell Immunology (2 papers). Stuart W. Bright collaborates with scholars based in United States. Stuart W. Bright's co-authors include Alexei Kharitonenkov, Michael D. Knierman, John E. Hale, Liyun Ding, Tamer Coşkun, Chen Zhang, Armen B. Shanafelt, Radmila Micanovic, Julie S. Moyers and Holly A. Bina and has published in prestigious journals such as Science, Life Sciences and Journal of Cellular Physiology.

In The Last Decade

Stuart W. Bright

8 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart W. Bright United States 5 369 87 70 55 37 8 516
Suresh Guruswamy United States 11 411 1.1× 140 1.6× 110 1.6× 64 1.2× 89 2.4× 16 608
Huanchun Zhang United States 13 470 1.3× 65 0.7× 30 0.4× 86 1.6× 38 1.0× 20 672
Toru Yanagimoto Japan 9 234 0.6× 72 0.8× 45 0.6× 20 0.4× 34 0.9× 12 408
Parijat Senapati India 15 611 1.7× 139 1.6× 59 0.8× 58 1.1× 35 0.9× 28 861
Julie-Ann Hulin Australia 13 297 0.8× 88 1.0× 31 0.4× 50 0.9× 46 1.2× 24 464
Keng-Mean Lin United States 6 397 1.1× 114 1.3× 99 1.4× 79 1.4× 20 0.5× 7 718
Mariarosa Perotti Italy 8 268 0.7× 47 0.5× 28 0.4× 26 0.5× 28 0.8× 16 495
Huaqin Zhang China 12 279 0.8× 58 0.7× 22 0.3× 37 0.7× 17 0.5× 19 470
Patrik Strömberg Sweden 13 185 0.5× 36 0.4× 22 0.3× 39 0.7× 33 0.9× 20 456
Valdemar Hial Brazil 10 180 0.5× 102 1.2× 61 0.9× 34 0.6× 17 0.5× 18 494

Countries citing papers authored by Stuart W. Bright

Since Specialization
Citations

This map shows the geographic impact of Stuart W. Bright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart W. Bright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart W. Bright more than expected).

Fields of papers citing papers by Stuart W. Bright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart W. Bright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart W. Bright. The network helps show where Stuart W. Bright may publish in the future.

Co-authorship network of co-authors of Stuart W. Bright

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart W. Bright. A scholar is included among the top collaborators of Stuart W. Bright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart W. Bright. Stuart W. Bright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Okragly, Angela J., Oliver C. Schroeder, Qing Zhang, et al.. (2021). Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33. Journal of Inflammation Research. Volume 14. 3823–3835. 9 indexed citations
2.
Bright, Stuart W., Sean E. Sissons, Pankaj Oberoi, et al.. (2018). Measurement of IL-21 in human serum and plasma using ultrasensitive MSD S-PLEX® and Quanterix SiMoA methodologies. Journal of Immunological Methods. 466. 9–16. 19 indexed citations
3.
Kharitonenkov, Alexei, James D. Dunbar, Holly A. Bina, et al.. (2007). FGF‐21/FGF‐21 receptor interaction and activation is determined by βKlotho. Journal of Cellular Physiology. 215(1). 1–7. 284 indexed citations
4.
Bright, Stuart W., et al.. (1997). Monoclonal antibodies as surrogate receptors in a high throughput screen for compounds that enhance insulin sensitivity. Life Sciences. 61(23). 2305–2315. 2 indexed citations
5.
Sittampalam, G. Sitta, Philip W. Iversen, Steven D. Kahl, et al.. (1997). Design of Signal Windows in High Throughput Screening Assays for Drug Discovery. SLAS DISCOVERY. 2(3). 159–169. 47 indexed citations
6.
Bright, Stuart W., et al.. (1997). Development of a Whole Cell High Throughput Screen for Muscarinic Receptor Agonists. SLAS DISCOVERY. 2(2). 79–84. 1 indexed citations
7.
Dantzig, Anne H., JoAnn Hoskins, Linda B. Tabas, et al.. (1994). Association of Intestinal Peptide Transport with a Protein Related to the Cadherin Superfamily. Science. 264(5157). 430–433. 153 indexed citations
8.
Bright, Stuart W., et al.. (1986). Detection of Infectious Pancreatic Necrosis Virus Using an Inhibition Enzyme-Linked Immunosorbent Assay. Journal of Immunoassay. 7(4). 229–239. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026